title: Beneficial effects of eicosapentaenoic acid for diabetic patients with arteriosclerosis obliterans.
authors: Y
authors: Y
authors: Okuda
authors: M
authors: M
authors: Mizutami
authors: K
authors: K
authors: Tanaka
authors: M
authors: M
authors: Isaka
authors: K
authors: K
authors: Yamashita
mesh_terms: D000368:Aged; D001162:Arteriosclerosis Obliterans / Q000188:drug therapy* / Q000503:physiopathology; D003924:Diabetes Mellitus, Type 2 / Q000503:physiopathology*; D003925:Diabetic Angiopathies / Q000188:drug therapy* / Q000503:physiopathology; D015118:Eicosapentaenoic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D005260:Female; D006439:Hemodynamics; D006801:Humans; D008297:Male
chemical_list: C035276:eicosapentaenoic acid ethyl ester; D015118:Eicosapentaenoic Acid